With the hope of understanding how interleukin (IL)-4 and IL-13 modulated quality of anti-viral CD8
Introduction
Protection against intracellular pathogens (e.g. viruses and parasites) and tumors often requires the activation of effector CD8 + T cells, which usually mediate cytolysis upon recognition of non-self peptide-major histocompatibility complex class I complexes presented on the surface of malignant cells or virus-infected cells [1] [2] [3] . However, a collection of CD8 + T cell effector functions, not exclusively cytolysis, appears to be important in controlling virus infections. These include the ability to mount high avidity interactions with virus-infected targets, produce multiple anti-viral cytokines (i.e. IFN-c and TNF-a), induce a high clonal turnover rate, and/or the ability to produce chemoattractants (e.g. macrophage inflammatory protein-1b) to recruit immune cells to virus-infected sites [4] [5] [6] . These effector functions define the quality of effector CD8 + T cell responses against viruses.
IL-4 and IL-13 are closely related cytokines mostly studied for their involvement in allergic diseases (e.g. asthma) and parasitic infections. In our previous studies we have for the first time demonstrated that both IL-4 and IL-13 dampen the avidity of human immunodeficiency virus (HIV)-specific CD8
+ T cells in a pox-viral prime-boost vaccination model in mice [7] [8] . Other studies also have shown that exposure of CD8 + T cells to IL-4 during primary activation results in the differentiation of effector CD8 + T cells with excessively reduced CD8 co-receptor expression, poor cytotoxic capacity, poor IFN-c production and enhanced IL-4 production in vitro and in vivo [9] [10] [11] . IL-4 and IL-13 share many biological functions due to their ability to signal through a unique network of complex receptors. IL-4 can signal through the type I IL-4 receptor (heterodimer of IL-4Ra and common c (cc) chains) and the type II IL-4 receptor (heterodimer of IL-4Ra and IL-13 receptor a 1 (IL-13Ra1) chains), but IL-13 only signals through the type II IL-4 receptor [12, 13] . IL-4 and IL-13 cytokine responses can be completely abrogated on cells lacking IL-4Ra expression as it is a component of both type I and type II IL-4 receptors [14] [15] . IL-13 binds with higher affinity to IL-13 receptor a 2 (IL-13Ra2) compared to IL13Ra1, but binding of IL-13 to IL-13Ra2 does not result in signaling [16] . IL-13Ra2 has been shown to be important in dampening IL-13 signaling and protecting mice against allergen induce dermatitis [17] . Hence, IL-13Ra2 is thought to function as an IL-13 decoy/inhibitor receptor. IL-4 and IL-13 cellular signaling via the type I or type II IL-4 receptors leads to activation of STAT6, which facilitates transcription of IL-4/IL-13 responsive genes [18] [19] .
The use of IL-4Ra 2/2 , IL-13Ra1 2/2 , cc 2/2 and IL-13Ra2 2/2 mice have shown that these receptors are indeed important for controlling functions of IL-4 and IL-13 in allergic diseases and parasitic infections [15, 17, 20] . However, these studies provide limited insight as to how these receptors are regulated at a cellular level in vivo during the course of a pathogenic infection. Recent study by Tanaka et al [21] reported that cell surface IL-4Ra expression is down-regulated on activated CD4 + T cells in vivo following L. major infection. This was found to be due to degradation of IL-4Ra in intracellular compartments of activated CD4
+ T cells in a T cell receptor and dedicator of cytokinesis 2 dependent manner [21] . In another study, Perona-Wright et al [22] have also shown that cell surface IL-4Ra expression was down-regulated on activated CD4 + T cells following H. polygyrus infection of mice, which was thought to render these cells refractory to further stimulation with IL-4. On the contrary, naïve bystander CD4
+ T cells in this instance were found to up-regulate IL-4Ra making them more responsive to IL-4 [22] . These studies suggest that IL-4Ra play a critical role in tuning responsiveness of CD4 + T cells to IL-4 and/or IL-13 during infection with pathogens.
Despite recent studies showing the importance of regulating IL4Ra expression on CD4 + T cells following parasitic infection in vivo, only few studies have addressed how the cytokine receptors for IL-4/IL-13 are regulated on CD8 + T cells following virus infection in vivo. As our previous studies have shown that IL-4 and IL-13 play an important role in modulating the quality of anti-viral CD8 + T cell immunity [7] [8] , in this study we further investigated how IL-4Ra, cc, IL-13Ra1 and IL-13Ra2 were regulated on CD8 + T cells and other immune cells predominantly following VV infection of mice. Results indicated that IL-4Ra expression, but not cc, IL-13Ra1 or IL-13Ra2 was differentially regulated on CD8
+ T cells as a consequence of VV infection of mice. Therefore, the current study focused on the mechanisms involved in the regulation of IL-4Ra on CD8 + T cells following virus infection and whether differential regulation of IL-4Ra on CD8 + T cells affects the quality of anti-viral CD8 + T cell immunity.
Results

Regulation of IL-4/IL-13 receptor components during VV infection
To examine whether VV infection induced differential regulation of IL-4/IL-13 receptor subunits on immune cells known to be important for clearance of viral infections, splenocytes from unimmunized or VV Western Reserve (VV-WR) strain infected BALB/c WT mice were analyzed using flow cytometry during the peak (i.e. 7 days) of anti-viral immunity. Cell surface IL-13Ra1, cc and intracellular IL-13Ra2 expression levels on gated B220 figure 4B and 4C ). There were no significant differences between the levels of cell surface IL-4Ra expression on effector CD8
+ T cells or naïve CD8 + T cells that developed following VV-WR infection and other viral infections (figure 4B and 4C). Therefore, down-regulation of cell surface IL4Ra expression on activated CD8
+ T cells is a general feature of virus infections in vivo.
Importance of IL-4, IL-13, IFN-c and STAT6 in regulating IL-4Ra expression on CD8 + T cells following virus infection
IL-4, IL-13 and IFN-c are cytokines that play a role in regulating IL-4Ra expression on cells [12, 24] . Thus, we next determined whether down-regulation of cell surface IL-4Ra expression on anti-viral effector CD8
+ T cells was dependent on IL-4, IL-13, STAT6 or IFN-c. For this purpose, IL-4Ra expression was analyzed on effector (GzmB + CD62L 2 ) and naïve (GzmB 2 CD62L + ) CD8 + T cells from relevant gene knockout mice and littermate WT control mice infected with VV-WR. Cell surface IL-4Ra expression on naïve CD8
+ T cells, but not effector CD8 + T cells was significantly lower in BALB/c IL-4 2/2 , BALB/ c IL-13 2/2 and BALB/c STAT6 2/2 mice compared to BALB/c WT control mice ( figure 5A and 5B). We also examined whether a similar trend applied to CD4 + T cells in these experiments. However, when comparing cell surface IL-4Ra expression on naïve (CD62L hi CD44 lo ) or effector (CD62L lo CD44 hi ) CD4 + T cells from WT mice and gene knockout mice, no differences were observed (data not shown).
In these experiments, we also compared IL-4Ra expression levels on naïve CD8
+ T cells from VV-WR infected mice and unimmunized mice. This was done to investigate the possibility that VV-WR infection induced IL-4 and/or IL-13 to up-regulate IL-4Ra expression on naïve bystander CD8 + T cells similar to what has been reported on naïve bystander CD4 + T cells responding to IL-4 following parasitic infection [22] . However, naïve CD8
+ T cells from VV-WR infected BALB/c IL-13 2/2 , BALB/c IL-4 2/2 , BALB/c STAT6 2/2 , or BALB/c WT mice expressed similar levels of cell surface IL-4Ra to that of naïve CD8 + T cells from unimmunized mice belonging to the respective genetic background ( figure 5C ). This suggests that VV-WR infection was not inducing significant levels of IL-4 and/or IL-13 to up-regulate IL-4Ra expression on naïve CD8 + T cells. In contrast to the knockout mice described above, no difference in IL-4Ra expression levels were seen on any CD8 + T cells from C57BL/6 IFN-c 2/2 compared to C57BL/6 WT controls ( figure 5A and 5B). Collectively, data suggest that IL-4, IL-13 and STAT6 are required for maintaining high levels of IL-4Ra expression on naïve CD8 + T cells.
Increased IL-4 during virus infection induces higher levels of IL-4Ra on CD8 + T cells
Next we investigated whether IL-4Ra levels on CD8 + T cells were fixed/unchanged, or responsive to IL-4 during infection. For these studies VV co-expressing murine IL-4 and hemagglutinin (HA), namely VV-HA-IL-4 [25] , and the control VV coexpressing HA (VV-HA) were used. Strikingly, IL-4Ra expression was higher in BALB/c WT mice infected with VV-HA-IL-4 relative to VV-HA infection when comparing naïve (GzmB figure 6 ). However, when the same experiment was performed using BALB/ c STAT6 2/2 mice, no difference in IL-4Ra expression was observed (figure 6). Data indicate that the amount of IL-4 available IL-4 and IL-13 regulate the establishment of IFN-c
cells following virus infection
High avidity virus-specific CD8 + T cells express elevated levels of both IFN-c and TNF-a [8, 26] . To evaluate whether differential regulation of cell surface IL-4Ra expression on CD8 + T cells may play a role in regulating CD8
+ T cell functional quality, IFN-c and TNF-a production were measured using ICS following in vitro 
Discussion
Our results clearly indicated that amongst the different IL-4/IL-13 receptor components only cell surface IL-4Ra expression was significantly down-regulated on activated CD8
+ T cells following virus infection. IL-4, IL-13 and STAT6 were required to elevate IL-4Ra expression on naïve CD8
+ T cells, but not IFN-c. VV-HA-IL-4 infection studies showed that IL-4 and STAT6 was required to up-regulate IL-4Ra expression on naïve and effector CD8 + T cells. In all these studies higher IL-4Ra expression on CD8 + T cells strongly correlated with the reduction in polyfunctional or IFN-c + TNF-a + anti-viral CD8 + T cells. Thus, we
propose that regulation of IL-4Ra expression during virus infection plays an important role in regulating the quality of anti-viral CD8 + T cell immunity. Contrary to other studies [12] , our data showed that IL-13Ra1 is ubiquitously expressed on CD4 + T cells, CD8 + T cells, B cells, natural killer cells and DCs. Similar ubiquitous expression on immune cells was also observed with respect to IL-4Ra, cc, and IL-13Ra2. However, following virus infection only IL-4Ra was notably differentially regulated on certain immune cell subsets (i.e. CD4
+ T cells, CD8 + T cells and DCs). The mechanisms responsible for regulating IL-4Ra expression on CD4 + T cells and DCs following virus infection were not investigated in this study and warrants further investigation especially given the importance of these cell subsets in driving immune responses that help control intracellular pathogens [4, 27] .
In an acute lymphocytic choriomeningitis virus (LCMV) adoptive transfer model, Wherry et al [28] have reported changes in many cellular markers, including IL-4Ra expression on Involvement of IL-4Ra in CD8+ T Cell Quality PLOS ONE | www.plosone.orgtransferred LCMV DbGP33-specific transgenic P14 CD8 + T cells. In their model, IL-4Ra expression was down-regulated on LCMV DbGP33-specific CD8 + T cells following acute and chronic LCMV infection. These findings are consistent with the findings of the current study. However, unlike the current study, Wherry et al [28] did not investigate the factors responsible for regulating IL4Ra expression on polyclonal CD8 + T cells or the implications of regulating this receptor on CD8 + T cell functionality following virus infection in WT mice.
IL-4 can induce the activation of STAT1, STAT3, STAT5 and STAT6 on naïve and activated CD8 + T cells in vitro [29] , but our infections studies with VV-HA-IL-4 indicated that STAT6 was indispensible for IL-4 mediated up-regulation of cell surface IL4Ra expression on naïve and effector CD8 + T cells. Even in naïve gene knockout mice STAT6 signaling, which appeared to be optimal in the presence of both IL-4 and IL-13, was required to maintain high levels of cell surface IL-4Ra expression on CD8 + T cells. Thus, our data indicated that IL-4 and/or IL-13 signaling through STAT6 was important in maintaining high levels of IL4Ra expression on naïve CD8 + T cells even when no pathogen is encountered. Furthermore, this signaling mechanism also appears to be important in elevating IL-4Ra expression on naïve and effector CD8 + T cells in vivo following virus infection. However, a caveat in this interpretation is that deficiency of STAT6 in other cells may play a role in regulating IL-4Ra expression levels on CD8 + T cells. Previous infection studies with VV-HA-IL-4 or recombinant ectromelia virus encoding IL-4 suggested that IL-4 dampened the effector function capacity of anti-viral CD8 + T cells and enhanced viral pathogenesis [25, 30] . In chronic HIV progressors, HIVspecific CD8
+ T cells with reduced cytolytic capacity have been reported to express IL-4 [31] . In our laboratory, following HIV-1 pox-viral prime-boost vaccination, both IL-4 and IL-13 were found to dampen the avidity of HIV-specific CD8 + T cells [7] . However, none of the above studies have monitored the expression of IL-4Ra in conjunction with the anti-viral effector functions on CD8 + T cells. We have addressed this in the current study and our data suggest that enhancing CD8 + T cell responsiveness to IL-4 and/or IL-13 via STAT6 dependent upregulation of IL-4Ra expression can exacerbate the quality (IFN-c and TNF-a cytokine production) of anti-viral CD8 + T cell immunity.
Paradoxical to these studies, we have also shown that HIVspecific CD8
+ T cells that developed in IL-4Ra 2/2 mice following HIV-1 prime-boost vaccination expressed high levels of IL-4 and IL-13, but low levels of IFN-c [7] . Other studies using IL-4Ra 2/2 mice have also shown that IL-4Ra is required for the maintenance of optimal CD8 + T cell cytotoxicity, IFN-c production and memory responses [32] [33] . It is highly likely that in IL-4Ra 2/2 mice, other compensatory mechanisms may play a role in dampening CD8 + T cell functionality as Mohrs et al [34] have shown that T helper 2 differentiation can still occur in IL4Ra 2/2 mice in vivo. Identification of these compensatory mechanisms may not only help understand mechanisms important for regulating T cell quality, but also help reconcile the paradoxical findings discussed above.
The exact mechanisms as to how IL-4 and/or IL-13 mediated elevation of IL-4Ra expression on CD8 + T cells act to dampen IFN-c and TNF-a cytokine production by anti-viral CD8 + T cells was not addressed in this study. It is possible that activation of suppressor of cytokine signaling (SOCS)-1 and -3 on anti-viral CD8 + T cells is important for this effect as IL-4 and IL-13 mediated activation of these transcription factors have been shown to dampen IFN-c and TNF-a cytokine production by keratinocytes [35] . IL-4 has also been shown to down-regulate the CD8 coreceptor expression levels on antigen-specific CD8 + T cells, which dampens the functionality of these cells [9] [10] [11] . Therefore, IL-4 and/or IL-13 mediated regulation of the CD8 co-receptor expression levels on anti-viral CD8 + T cells may also play a role in regulating anti-viral cytokine production and this is currently being evaluated in an HIV-1 pox viral prime-boost vaccination model (Wijesundara et al manuscript in preparation).
To our understanding, this is the first study to evaluate how the different cellular receptor components for IL-4 and IL-13 are regulated on CD8 + T cells following virus infection. Our data suggested that differential regulation of IL-4Ra, unlike other IL-4/ IL-13 receptor components (i.e. cc, IL-13Ra1 and IL-13Ra2) play a more critical role in determining the responsiveness of CD8 + T Figure 5 . IL-4, IL-13 and STAT6 regulate IL-4Ra expression on CD8 + T cells following VV-WR infection. Gene knockout mice (n = 5) and respective littermate WT control mice (n = 5) were infected with VV-WR for 7 days or kept unimmunized prior to sacrifice and analysis using flow cytometry. A, Representative histogram plots showing cell surface IL-4Ra expression on the indicated CD8 + splenocyte subset from a gene knockout mouse or a littermate WT control mouse. B, Mean (n = 5) MFI representing cell surface IL-4Ra expression on the indicated CD8 + splenocyte subset from mice of the indicated genetic background infected with VV-WR. C, Representative histogram plots showing cell surface IL-4Ra expression on the indicated CD8 + splenocyte subset from an unimmunized mouse or VV-WR infected mouse belonging to the indicated genetic background. All the results shown are representative of at least two independent experiments. Error bars when shown depict the SEM and one-way ANOVA (Tukey's Multiple Comparison) was used to determine the statistical significance of the data relative to WT control mice (*** -p,0.001). doi:10.1371/journal.pone.0055788.g005 cells to IL-4 and/or IL-13 in order to regulate the quality of antiviral CD8 + T cell immunity. This is consistent with our previous studies where IL-4 and IL-13 were shown to play an important role in modulating the avidity of HIV-specific CD8 + T cell responses following prime-boost vaccination [7, 8] . Thus, we believe that the current findings could be exploited to design more effective pox viral-vectored vaccines against chronic infections such as HIV-1 where robust CD8 + T cell immunity is required for protection. Furthermore, given that IL-4Ra is constitutively expressed on T cells, it may easily be used as a novel biomarker to assess T cell quality following vaccination.
Materials and Methods
Mice
Pathogen-free 6-8 weeks old female BALB/c WT, BALB/c IL-4 2/2 , BALB/c IL-13 2/2 , BALB/c STAT6 2/2 , C57BL/6, C57BL/6.SJL (CD45.1) and T cell receptor transgenic C57BL/6 OT-I (CD45.2) mice were all purchased from the Australian Phenomics Facility, the Australian National University. Associate Professor Guna Karupiah kindly provided the C57BL/6 IFN-c 2/ 2 mice used in this study.
Ethics statement
All animals were maintained and experiments were performed in accordance with the Australian NHMRC guidelines within the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes and in accordance with guidelines approved by the Australian National University Animal Experimentation and Ethics Committee (AEEC), protocol numbers JIG 74.09 and A2011/018. All animals were monitored daily, infected mice were scored for signs of illness and weight loss. Animals were ethically sacrificed using cervical dislocation in accordance with the above AEEC approved protocols.
Peptide synthesis
VV immunodominant A52 75-83 (KYGRLFNEI) and F2L [26] [27] [28] [29] [30] [31] [32] [33] [34] (SPYAAGYDL) peptides were synthesized by the Biomolecular Resource Facility, the John Curtin School of Medical Research.
Virus and infection
VV-WR strain and recombinant VV-OVA 257-264 were grown and titrated in 143B cells. Recombinant VV-HA-IL-4 and the control VV-HA were prepared as described in Sharma et al [25] . These stocks were kindly provided by Professor Alistair Ramsay. FPV were grown and titrated in chick embryonic epithelial cells. Dr. David Boyle kindly provided the FPV parent stocks. MVA, aSFV and A/PR8 (H1N1) influenza virus stocks used in this study were gifts from Associate Professor Guna Karupiah, Dr. Mohammed Alsharifi and Dr. Yoichi Furuya, respectively.
All virus infections in age-and sex-matched mice were conducted intraperitoneally (i.p.) at a dose of 3610 6 plaque forming units (PFU)/mouse or 5610 6 PFU/mouse for a period of 7 days unless otherwise stated. 
Adoptive cell transfer
Flow cytometry
The following monoclonal antibodies against mouse antigens and the respective isotype controls for CD8a, CD4, CD45R (B220), CD124 (IL-4Ra), CD132 (cc), CD49b (DX5), CD62L, CD11c and TNF-a were all obtained from Becton Dickinson (BD) Biosciences, USA. Monoclonal antibodies against mouse GzmB, CD45.2 and I-A d were obtained from BioLegend, USA and monoclonal antibodies against mouse CD213a (IL-13Ra1) and IFN-c were obtained from eBioscience, USA. These antibodies were used as purified, fluorescein isothiocyanate, phycoerythrin, peridinin chlorophyll protein, pacific blue, or allophycocyanin conjugates. Secondary fluorescein isothiocyanate conjugated antigoat IgG (Jackson Immuno Research, USA) was used to detect + IFN-c + splenocytes that also produced TNF-a from the indicated mice infected with VV-WR. The data presented in all panels are representative of at least two independent. Error bars depict the SEM and statistical significance was determined using a one-way ANOVA (Tukey's Multiple Comparison) relative to WT control mice (* -p,0.05; *** -p,0.001). doi:10.1371/journal.pone.0055788.g007 purified polyclonal goat IgG anti-mouse IL-13Ra2 (R&D systems, USA) binding to splenocytes.
In all flow cytometry-based studies RBC-depleted splenocytes were used. Cell surface staining and intracellular staining were performed using the respective method described in Ranasinghe et al [36] . Briefly, for cell surface staining 1-2610 6 cells were incubated 30 minutes at 4uC in the presence of purified or fluorochrome conjugated antibodies diluted in phosphate buffer saline containing 1% fetal calf serum (FCS). Subsequently, samples were washed twice using phosphate buffer saline containing 1% FCS, fixed in 0.5% paraformaldehyde, prior to analysis. In all the experiments described here, intracellular GzmB staining of cell surface stained samples were conducted using freshly isolated RBC-depleted splenocytes that were not stimulated with peptides. For IFN-c and TNF-a ICS, 1610 6 cells in 200 ml of Roswell Park Memorial Institute culture medium (Invitrogen, Australia) containing 10% FCS were seeded in 96 well U-bottom plates in the presence or absence of 0.1 mg/ml of A52 75-83 or F2 [26] [27] [28] [29] [30] [31] [32] [33] [34] peptides. Subsequently, peptide stimulated or unstimulated cultures were left for 1 hour at 37uC + 5% CO 2 prior to addition of 16 Brefeldin A (eBioscience, USA). The cultures were then left for further 4 hours at 37uC+5% CO 2 prior to conducting cell surface staining as described before. Cell surface stained samples were fixed and permeabilized using commercial intracellular fixation and permeabilization buffers according to the manufacturer's protocol (eBioscience, USA). Subsequently, permeabilized cells were incubated 30 minutes at 4uC in the presence of purified or fluorochrome conjugated antibodies diluted in 16 permeabilization buffer (eBioscience, USA). Intracellular stained samples were washed twice using phosphate buffer saline containing 1% FCS, fixed in 0.5% paraformaldehyde prior to analysis. All cell surface and intracellular stained samples were analyzed using FACS Calibur (BD Biosciences, USA) or BD LSR II (BD Biosciences, USA) machine. Flow cytometry plots of the analyzed data were constructed using the FlowJo Tree Star software (version 8.7.1).
Statistical analysis
Net fold reduction of cell surface IL-4Ra expression was calculated using mean fluorescent intensity (MFI) obtained from flow cytometry on gated CD8 + splenocytes from unimmunized or VV-WR infected mice as follows: ((MFI (IL-4Ra) unimmunized 2MFI (IL-4Ra) VV-WR )/ MFI (IL-4Ra) unimmunized ). All the data presented in this study have been reproduced in at least two independent experiments. The data plotted in all the graphs shown represent the mean and the error bars depict the standard error of the mean (SEM). Statistical significance of the data and the p values were calculated using the Graph InStat software (version 3.10). In all statistical significance analysis, a student's unpaired t-test or one-way ANOVA (Tukey's Multiple Comparison post-hoc test) was used. The p values are denoted as follows: * -p,0.05, ** -p,0.01, and *** -p,0.001.
